(Q33742335)

29 July 2017

1 reference

title

Regulation of osteoclast activity (English)

1 reference

29 July 2017

Greenfield EM

1

1 reference

29 July 2017

Bi Y

series ordinal

2

1 reference

29 July 2017

Miyauchi A

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

65

1 reference

29 July 2017

11

1 reference

29 July 2017

1087-1102

1 reference

Cytokines and estrogen in bone: anti-osteoporotic effects

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Regulation of osteoclast function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoclast differentiation requires ascorbic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Role of osteoblasts in hormonal control of bone resorption—A hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Interleukin-6: an osteotropic factor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

The bone-resorbing activity of interleukin-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Induction of bone resorption in tissue culture. Prolonged response after brief exposure to parathyroid hormone or 25-hydroxycholecalciferol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Cell type and stimulus specific regulation of chemokine gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

A differentiation-inducing factor produced by the osteoblastic cell line MC3T3-E1 stimulates bone resorption by promoting osteoclast formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Leukemia Inhibitory Factor: A Novel Bone-Active Cytokine*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Interleukin-11: a new cytokine critical for osteoclast development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Cytokine signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Death receptors: signaling and modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Tyro 3 receptor tyrosine kinase and its ligand, Gas6, stimulate the function of osteoclasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

7 January 2021

Protons and osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Modulation of the resorptive activity of rat osteoclasts by small changes in extracellular pH near the physiological range.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Extracellular protons acidify osteoclasts, reduce cytosolic calcium, and promote expression of cell-matrix attachment structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Chronic extracellular acidosis induces plasmalemmal vacuolar type H+ ATPase activity in osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

A new action of parathyroid hormone. receptor-mediated stimulation of extracellular acidification in human osteoblast-like SaOS-2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

ATP is a potent stimulator of the activation and formation of rodent osteoclasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

ATP as an osteoclast regulator?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

The effect of hepatocyte growth factor on the behaviour of osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Calcitonin receptor binding properties in bone and kidney of the chicken during the oviposition cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts*1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Clear zone in osteoclast function: role of podosomes in regulation of bone-resorbing activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

A ryanodine receptor-like molecule expressed in the osteoclast plasma membrane functions in extracellular Ca2+ sensing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Phosphate transport in osteoclasts: a functional and immunochemical characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Regulation of sodium-dependent phosphate transport in osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Echistatin is a potent inhibitor of bone resorption in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

ArgGlyAsp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts*1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Pathogenesis of induced rat periapical lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Shedding of tumor necrosis factor receptors by activated human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Interleukin-1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoclasts from Human Giant Cell Tumors of Bone Lack Estrogen Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Cystatin C, and inhibitor of bone resorption produced by osteoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Bone marrow cells produce soluble factors that inhibit osteoclast activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Stimulation of Bone Resorption by Parathyroid Hormone in Tissue Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Microcytophotometric analysis of human osteoclast metabolism: lack of activity in certain oxidative pathways indicates inability to sustain biosynthesis during resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Avian osteoblast conditioned media stimulate bone resorption by targeting multinucleating osteoclast precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoclast demise in the rat: physiological versus degenerative cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

DNA fragmentation during bone formation in neonatal rodents assessed by transferase-mediated end labeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Calcitonin promotes osteoclast survival in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Caspases (interleukin-1beta-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Tumor osteolysis in osteopetrotic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

Effects of transforming growth factor β1 on the regulation of osteoclastic development and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900156-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(99)00156-3

1 reference

release_jyh4kxkcezdtta544hi3fscsmm

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jyh4kxkcezdtta544hi3fscsmm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference